Abstract: Leptospirosis is a globally distributed zoonosis that affects both humans and animals, with being the main causative agent. In horses, the disease is associated with considerable economic losses. The Microscopic Agglutination Test (MAT) is the reference test for diagnosis but has limitations, emphasizing the need for effective diagnostic alternatives. In this study, was evaluated the use of a recombinant chimera, composed of ErpY-like and LemA proteins, as an antigen for ELISA-based detection of equine leptospirosis. The chimera was successfully expressed, purified and tested on 915 horse serum samples previously analyzed by MAT. The ELISA correctly identified all positive samples, with no false negative observed. The ROC curve analysis, considering different hypothetical prevalence values, reached up to 0.92. The assay demonstrated sensitivity ranging from 98.8% to 100%, specificity from 77.6% to 84%, positive predictive value between 68.6% and 77.2%, and negative predictive value between 92% and 100%. The Kappa coefficient was 0.7432, indicating good agreement with MAT. When samples were categorized by titers, those with a 1:400 dilution achieved the highest accuracy (99%), while those with a 1:100 dilution showed slightly lower accuracy (94.8%), demonstrating that higher antibody titers resulted in a more effective assay. The major serovars that cause infection in horses, such as Bratislava, Icterohaemorrhagiae, Sejroe, Pomona, and Copenhageni, react with rErpY-lemA. These results suggest that the ErpY-LemA chimera is a promising screening tool for equine leptospirosis, offering a valuable alternative for the rapid and accurate detection of different serovars and titers. The test demonstrated high sensitivity and specificity, with strong agreement with the MAT (Kappa value). No false negatives were identified, further confirming the test’s reliability. This is the first study to use a recombinant chimera for equine leptospirosis diagnosis. The recombinant ErpY-LemA chimera was successfully used as an antigen in an ELISA-based assay for diagnosing equine leptospirosis, proving to be a promising screening tool. [Image: see text]
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
Overview
This research evaluated a new ELISA test for detecting leptospirosis in horses, using a recombinant protein chimera as an antigen, showing it to be a reliable alternative to the standard diagnostic method.
Background on Leptospirosis and Diagnosis Challenges
Leptospirosis is a widespread zoonotic disease affecting both humans and animals, including horses.
The disease in horses causes important economic impacts due to illness.
The current reference diagnostic method is the Microscopic Agglutination Test (MAT), which has limitations such as complexity, requirement of live cultures, and potential inaccuracies.
There is a need for effective, rapid, and accurate alternative diagnostic methods.
Development of the ELISA-Based Assay Using Recombinant Chimera
A recombinant chimera combining two Leptospira proteins, ErpY-like and LemA, was created to be used as the antigen in the ELISA test.
This chimera was successfully expressed and purified for use in diagnostics.
The purpose was to detect antibodies in horse serum samples, indicating leptospirosis infection.
Testing and Validation of the ELISA Assay
915 horse serum samples previously tested with MAT were used to validate the ELISA test.
The ELISA assay correctly identified all positive cases, demonstrating zero false negatives.
Sensitivity of the test ranged from 98.8% to 100%, showing it is highly effective at identifying infected horses.
Specificity ranged from 77.6% to 84%, indicating a good ability to correctly identify non-infected horses.
Positive Predictive Value (PPV) ranged between 68.6% and 77.2%, meaning most positive results are true positives.
Negative Predictive Value (NPV) ranged between 92% and 100%, meaning negative results are highly reliable.
The ROC curve analysis showed an area under the curve (AUC) of up to 0.92, reflecting very good test accuracy.
The Kappa coefficient was 0.7432, indicating good agreement between ELISA and MAT results.
Performance by Antibody Titer Levels
Samples were grouped by antibody dilution titers to evaluate test accuracy at different infection levels.
Samples with a 1:400 dilution had the highest accuracy of 99%, showing the test works best with higher antibody concentrations.
Samples with a 1:100 dilution still had good accuracy at 94.8%, though slightly less than higher titers.
This suggests the ELISA test sensitivity improves with higher antibody levels in serum.
Spectrum of Leptospira Serovars Detected
The recombinant ErpY-LemA chimera reacted to antibodies against major equine-infecting Leptospira serovars: Bratislava, Icterohaemorrhagiae, Sejroe, Pomona, and Copenhageni.
This broad reactivity means the ELISA can effectively detect infections caused by multiple important serovars.
Conclusions and Significance
The study represents the first reported use of a recombinant chimera protein in diagnosing equine leptospirosis via ELISA.
The test offers a valuable alternative to the MAT, with advantages including rapidity, ease of use, and high sensitivity/specificity.
No false negatives occurred, highlighting the test’s reliability for screening purposes.
The recombinant ErpY-LemA-based ELISA is a promising screening tool that can improve surveillance and management of equine leptospirosis by enabling accurate and timely detection.
Cite This Article
APA
Cardoso TL, Wozeak DR, Pereira IL, da Silva Ribeiro LD, Rodrigues RO, Hartwig DD.
(2026).
Advances in ELISA-based detection of equine leptospirosis.
Braz J Microbiol, 57(1), 52.
https://doi.org/10.1007/s42770-025-01854-z
Bacteriology and Bioassays Laboratory, Department of Microbiology and Parasitology, Institute of Biology, Federal University of Pelotas, Pelotas, RS, Brazil.
Biotechnology Center, Biotechnology Development Center, Federal University of Pelotas, Pelotas, RS, CEP 96010-900, Brazil.
Wozeak, Daniela Rodriguero
Bacteriology and Bioassays Laboratory, Department of Microbiology and Parasitology, Institute of Biology, Federal University of Pelotas, Pelotas, RS, Brazil.
Biotechnology Center, Biotechnology Development Center, Federal University of Pelotas, Pelotas, RS, CEP 96010-900, Brazil.
Pereira, Isabel Ladeira
Bacteriology and Bioassays Laboratory, Department of Microbiology and Parasitology, Institute of Biology, Federal University of Pelotas, Pelotas, RS, Brazil.
Biotechnology Center, Biotechnology Development Center, Federal University of Pelotas, Pelotas, RS, CEP 96010-900, Brazil.
da Silva Ribeiro, Laura Dias
Bacteriology and Bioassays Laboratory, Department of Microbiology and Parasitology, Institute of Biology, Federal University of Pelotas, Pelotas, RS, Brazil.
Biotechnology Center, Biotechnology Development Center, Federal University of Pelotas, Pelotas, RS, CEP 96010-900, Brazil.
Rodrigues, Rogério Oliveira
Leptospirosis Laboratory, Department of Animal Diagnostics and Research, Secretariat of Agriculture, Livestock and Irrigation, Desidério Finamor Veterinary Research Institute, Eldorado do Sul, RS, Brazil.
Hartwig, Daiane Drawanz
Bacteriology and Bioassays Laboratory, Department of Microbiology and Parasitology, Institute of Biology, Federal University of Pelotas, Pelotas, RS, Brazil. daianehartwig@gmail.com.
Biotechnology Center, Biotechnology Development Center, Federal University of Pelotas, Pelotas, RS, CEP 96010-900, Brazil. daianehartwig@gmail.com.
Grant Funding
001 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul / Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
Conselho Nacional de Desenvolvimento Científico e Tecnológico / Conselho Nacional de Desenvolvimento Científico e Tecnológico
Conflict of Interest Statement
Declarations. Conflict of interest: The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper
References
This article includes 57 references
Soo ZMP, Khan NA, Siddiqui R. Leptospirosis: increasing importance in developing countries.. Acta Trop .
Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM. Leptospirosis: a zoonotic disease of global importance.. Lancet Infect Dis 3:757–771.
Bandara K, Weerasekera MM, Gunasekara C, Ranasinghe N, Marasinghe C, Fernando N. Utility of modified faine’s criteria in diagnosis of leptospirosis.. BMC Infect Dis 16:1–7.
Lilenbaum W, Varges R, Brandão FZ, Cortez A, de Souza SO, Brandão PE, Richtzenhain LJ, Vasconcellos SA. Detection of spp. in semen and vaginal fluids of goats and sheep by polymerase chain reaction.. Theriogenology 69:837–842.
Morais DDA, Costa DFD, Nunes BC, Santos CDSAB, Alves CJ, Azevedo SSD. Seroepidemiological survey for leptospirosis in equines from semiarid region of Paraíba state, Northeastern Brazil.. Semina: Ciências Agrárias 40:2079.
Morais DA, Nunes BC, Barnabé NNC, Anjos DM, Bezerra CS, Costa DF, Santos CSAB, Azevedo SS, Alves CJ. Spatial and seasonal distribution of spp. seropositive horses in the Northeast region of Brazil.. Prev Vet Med 231:106301.
Petrakovsky J, Bianchi A, Fisun H, Nájera-Aguilar P, Pereira MM. Animal leptospirosis in Latin America and the Caribbean countries: reported outbreaks and literature review (2002–2014).. Int J Environ Res Public Health 11:10770–10789.
Zacarias FGDS, Vasconcellos SA, Anzai EK, Giraldi N, De Freitas JC, Hartskeerl R. Isolation of serovars Canicola and Copenhageni from cattle urine in the State of Paraná, Brazil.. Braz J Microbiol 39:744–748.
Alizadeh S, Abdollahpour G, Pourmand M, Naserpour T, Najafipour R, Eshraghi S. Evaluation of new ELISA based on rLsa63 - rLipL32 antigens for serodiagnosis of human Leptospirosis, Iran.. J Microbiol 6:184–189.
De Abreu Fonseca C, de Teixeira Freitas VL, Caló Romero E, Spinosa C, Arroyo Sanches MC, Da Silva MV, Shikanai-Yasuda MA. Polymerase chain reaction in comparison with serological tests for early diagnosis of human leptospirosis.. Trop Med Int Health 11:1699–1707.
Mariya R, Chaudhary P, Kumar AA, Thangapandian E, Amutha R, Srivastava SK. Evaluation of a recombinant LipL41 antigen of serovar Canicola in ELISA for serodiagnosis of bovine Leptospirosis.. Comp Immunol Microbiol Infect Dis 29:269–277.
Surujballi O, Mallory M. An indirect enzyme linked immunosorbent assay for the detection of bovine antibodies to multiple serovars.. Can J Vet Res 68:1–6.
Ghosh KK, Prakash A, Dhara A, Hussain MS, Shrivastav P, Kumar P, Balamurugan V, Kumar M. Role of supramolecule ErpY-like lipoprotein of in thrombin-catalyzed fibrin clot inhibition and binding to complement factors H and I, and its diagnostic potential.. Infect Immun 87:e00536-19.
Cardoso TL, de Freitas SB, Balassiano IT, Hartwig DD. Advancing serologic diagnosis: assessing the efficacy of rErpY-like protein in human leptospirosis detection.. Braz J Microbiol .
Padilha BCR, Simão HQ, Oliveira TL, Hartwig DD. The use of ErpY-like recombinant protein from in the development of an immunodiagnostic test for swine leptospirosis.. Acta Trop 193:31–34.
Oliveira TL, Bacelo KL, Forster KM, Ilha V, Rodrigues OE, Hartwig DD. DNA nanovaccines prepared using LemA antigen protect golden Syrian hamsters against lethal infection. Mem Inst Oswaldo Cruz 115:1–6.
Hartwig DD, Forster KM, Oliveira TL, Amaral M, McBride AJA, Dellagostina OA. A prime-boost strategy using the novel vaccine candidate, LemA, protects hamsters against leptospirosis. Clin Vaccine Immunol 20:747–752.
Ávila-Martínez EG, Cardoso TL, Pereira IL, Caballero PS, Wozeak DR, Neto ACPS, da Silva Pinto L, Hartwig DD. Immunoinformatic approaches for ErpY-LemA chimeric protein design for use in leptospirosis control. J Appl Microbiol .
Behera SK, Sabarinath T, Ganesh B, Mishra PKK, Niloofa R, Senthilkumar K, Verma MR, Hota A, Chandrasekar S, Deneke Y, Kumar A, Nagarajan M, Das D, Khatua S, Sahu R, Ali SA. Diagnosis of human leptospirosis: comparison of microscopic agglutination test with recombinant LigA/B antigen-based in-house IgM dot ELISA dipstick test and latex agglutination test using bayesian latent class model and MAT as gold standard. Diagnostics 12:1455.
Dreyfus A, Ruf M-T, Goris M, Poppert S, Mayer-Scholl A, Loosli N, Bier NS, Paris DH, Tshokey T, Stenos J, Rajaonarimirana E, Concha G, Orozco J, Colorado J, Aristizábal A, Dib JC, Kann S. Comparison of the Serion IgM ELISA and microscopic agglutination test for diagnosis of spp. infections in sera from different geographical origins and estimation of seroprevalence in the Wiwa Indigenous population from Colombia. PLoS Negl Trop Dis 16:e0009876.
Jalii IME. Comparison between ELISA and the microscopic agglutination test for the diagnosis of bovine leptospirosis. .
Mulla S, Chakraborty T, Patel M, Pandya HP, Dadhaniya V, Vaghela G. Diagnosis of leptospirosis and comparison of ELISA and MAT techniques. Indian J Pathol Microbiol 49:468–470.
Sakhaee E, Abdollahpour G, Bolourchi M, Tabrizi SS. Comparison between microscopic agglutination test (MAT) and enzyme-linked immunosorbent assay (ELISA) for detection of leptospiral antibodies in cattle. Comp Clin Pathol 19:5–9.
Zin NM, Othman SN, Abd Rahman FR, Abdul Rachman AR. Evaluation of IgM LAT and IgM ELISA as compared to microscopic agglutination test (MAT) for early diagnosis of sp. Trop. Biomed. 36:1071–1080.
Martinez ML, Rodriguez MA, Irazu LE, Romero GN, Saraullo VR, Watanabe O, Hamer M, Grüne Loffler S, Samartino LE, Brihuega BF. New enzyme-linked immunoassay for the detection of specific antibodies against multiple serogroups in bovine sera. Comp. Immunol. Microbiol. Infect. Dis. 75:101609.
Fernandes LGV, Avelar KES, Romero EC, Heinemann MB, Kirchgatter K, Nascimento ALTO. A new recombinant multiepitope chimeric protein of is a promising marker for the serodiagnosis of leptospirosis. Trop Med Infect Dis 7:362.
Lewis FI, Torgerson PR. A tutorial in estimating the prevalence of disease in humans and animals in the absence of a gold standard diagnostic. Emerg Themes Epidemiol .
Iragorri N, Spackman E. Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis. Public Health Rev .
Maneewatchararangsri S, Doungchawee G, Kalambaheti T, Luvira V, Soonthornworasiri N, Vattanatham P, Chaisri U, Adisakwattana P. Evaluation of a genus-specific rGroEL1-524 IgM-ELISA and commercial ELISA kits during the course of leptospirosis in Thailand. Sci Rep 11:19785.
Signorini ML, Lottersberger J, Tarabla HD, Vanasco NB. Enzyme-linked immunosorbent assay to diagnose human leptospirosis: a meta-analysis of the published literature. Epidemiol Infect 141:22–32.
Wang L, Liu L, Hong X, Liu D, Cheng Z. A novel method for the storage and transport of biological samples of therapeutic proteins prior to the detection of analytes using ELISA. Sci Rep 11:8763.
Hartskeerl RA, Collares-Pereira M, Ellis WA. Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect 17:494–501.
Karpagam KB, Ganesh B. Leptospirosis: a neglected tropical zoonotic infection of public health importance-an updated review. Eur J Clin Microbiol Infect Dis 39:835–846.